Effect on the Gastrointestinal Absorption of Drugs from Different Classes in the Biopharmaceutics Classification System, When Treating with Liraglutide
Author:
Affiliation:
1. Novo Nordisk A/S, 2860 Søborg, Denmark
2. Phase I Services, Quintiles AB, SE-753 23 Uppsala, Sweden
3. Biopharmaceutics, Department of Pharmacy, Uppsala University, SE-751 23 Uppsala, Sweden
Funder
Novo Nordisk
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.5b00278
Reference33 articles.
1. Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
2. Food and Drug Administration (FDA). Victoza prescribinginformation. http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022341lbl.pdf. Accessed date April 9 2015.
3. European Medicines Agency (EMA). Summary of product characteristics– Victoza. http://www.emea.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001026/WC500050017.pdf. Accessed date April 9 2015.
4. Gastric emptying: a comparison of three methods
5. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Analyzing parametric influences driving age-associated changes in absorption using a PBPK-GSA approach;European Journal of Pharmaceutical Sciences;2024-11
2. Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancer;British Journal of Clinical Pharmacology;2024-08-06
3. A web-based scoping review assessing the influence of smoking and smoking cessation on antidiabetic drug meabolism: implications for medication efficacy;Frontiers in Pharmacology;2024-06-18
4. Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review;Drug Safety;2024-01-25
5. HIV Treatment and Obesity: What’s New?;Infectious Diseases;2023-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3